NYSEAMERICAN : STXS
Stereotaxis, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 0.89 USD (Oct 30, 2026, 10:15 AM EDT) · Market cap 89.18M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 86.43M |
| Enterprise Value | 81.12M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 10, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 100.20M |
| Shares Outstanding | 100.20M |
| Shares Change (YoY) | +11.11% |
| Shares Change (QoQ) | +1.15% |
| Owned by Insiders (%) | 17.87% |
| Owned by Institutions (%) | 29.41% |
| Float | 65.54M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.87 |
| Forward PS | 2.05 |
| PB Ratio | 6.90 |
| P/TBV Ratio | 34.27 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 2.70 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.42 |
| Quick Ratio | 0.91 |
| Debt / Equity | 0.30 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | -184.27% |
| Return on Assets (ROA) | -25.38% |
| Return on Invested Capital (ROIC) | -69.90% |
| Return on Capital Employed (ROCE) | -68.24% |
| Weighted Average Cost of Capital (WACC) | 11.10% |
| Revenue Per Employee | $229,527 |
| Profits Per Employee | -$180,053 |
| Employee Count | 131 |
| Asset Turnover | 0.62 |
| Inventory Turnover | 1.21 |
Taxes
| Measure | Value |
|---|
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.37 |
| 52-Week Price Change | -70.46% |
| 50-Day Moving Average | 1.22 |
| 200-Day Moving Average | 1.71 |
| Relative Strength Index (RSI) | 21.60 |
| Average Volume (20 Days) | 635,755 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 5.99M |
| Short Previous Month | 5.58M |
| Short % of Shares Out | 5.98% |
| Short % of Float | 9.14% |
| Short Ratio (days to cover) | 11.26 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 30.07M |
| Gross Profit | 16.71M |
| Operating Income | -19.64M |
| Pretax Income | -22.32M |
| Net Income | -23.59M |
| EBITDA | -18.06M |
| EBIT | -19.64M |
| Loss Per Share | -$0.24 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 10.49M |
| Total Debt | 5.17M |
| Net Cash | 5.32M |
| Net Cash Per Share | $0.05 |
| Equity (Book Value) | 17.48M |
| Book Value Per Share | 0.13 |
| Working Capital | 11.19M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -15.29M |
| Capital Expenditures | -213,000 |
| Depreciation & Amortization | 1.59M |
| Net Borrowing | n/a |
| Free Cash Flow | -15.50M |
| FCF Per Share | -$0.15 |
Margins
| Measure | Value |
|---|
| Gross Margin | 55.57% |
| Operating Margin | -65.33% |
| Pretax Margin | -74.24% |
| Profit Margin | -74.24% |
| EBITDA Margin | -60.06% |
| EBIT Margin | -65.33% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -11.11% |
| Shareholder Yield | -11.11% |
| Earnings Yield | -28.26% |
| FCF Yield | -17.94% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $3.00 |
| Price Target Difference | 247.79% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Jul 11, 2012 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -11.92 |
| Piotroski F-Score | 3 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |